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A B S T R A C T
Purpose: Online mental health programs can be eﬀective in reducing symptoms of depression, anxiety disorders,
substance use and suicidal ideation. However, most existing e-mental health programs focus on a single domain
of mental health, neglecting comorbidity. Furthermore, few programs are tailored to the symptom patterns of the
individual user. FitMindKit was designed to overcome the gaps of existing e-mental health programs, providing
tailored, transdiagnostic therapeutic content to address a range of comorbid mental health symptoms. A trial was
conducted to test the program's eﬃcacy.
Methods: Australian adults with elevated symptoms of depression, anxiety, suicidal ideation and/or substance
use were recruited through social media, with n= 194 randomised into a fully-automated trial of a 10-day brief
intervention. Participants were randomly allocated to receive FitMindKit tailored to their symptoms, an un-
tailored generic version of FitMindKit, or an attention control.
Results: Mixed model repeated measures ANOVA indicated that participants in both FitMindKit and the attention
control had signiﬁcant reductions in symptom composite scores. Eﬀects were not signiﬁcantly greater in the
FitMindKit program relative to control, either at post-test or 3-month follow-up. No eﬀects were detected for
speciﬁc decreases in depression, generalized anxiety, social anxiety, panic, suicidal ideation or alcohol/sub-
stance use. There were no signiﬁcant diﬀerences between the tailored and static versions in eﬀectiveness or
adherence. Participants in the tailored and static conditions were more satisﬁed than in the control condition,
with some evidence favouring the tailored condition. High attrition reduced power to ﬁnd eﬀects.
Conclusions: FitMindKit provides a model for addressing comorbid mental health symptoms in an online pro-
gram, using automated tailoring to symptom patterns. Modiﬁcations to the program are recommended, along
with the need for larger trials to test the eﬀects of tailoring on mental health outcomes.
1. Introduction
Mental and substance use disorder account for 6.6% of total disease
burden and 19.0% of disability burden globally (Institute for Health
Metrics and Evaluation, 2017). Unlike most other health conditions,
this burden is disproportionately observed among young people. De-
spite the high prevalence and burden of common mental disorders, only
one in three people with a mental health problem seeks help from a
health professional (Burgess et al., 2009). There is a pressing need for
better prevention, identiﬁcation and early treatment of mental health
problems in the community. Internet interventions have been shown to
be eﬀective, eﬃcient and cost-eﬀective in preventing and treating many
common mental disorders (Andrews et al., 2010; Griﬃths et al., 2010;
Batterham et al., 2015b). Online programs may also be eﬀective in
preventing the development of mental disorders, with up to a 30%
reduction in the risk of developing depression (Spek et al., 2007;
Cuijpers et al., 2005; Calear and Christensen, 2010). However, the
implementation of internet interventions into traditional treatment
services is often challenging and may not improve eﬃciencies
(Batterham et al., 2015b; Kenter et al., 2015).
In addition, there is high comorbidity between mental health and
substance use problems that is not fully addressed by existing online
programs. Up to 45% of adults with a common mental disorder meet
criteria for more than one disorder (Kessler et al., 2005; Slade et al.,
2009). Online programs aimed at treating comorbidity have been
shown to be eﬀective, even outperforming traditional services (Kay-
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Lambkin et al., 2009). In addition, programs that target depression and
anxiety more broadly using a transdiagnostic approach have been
shown to signiﬁcantly reduce symptoms (Titov et al., 2011). The po-
tential of online programs to address comorbidity has not been fully
realised. Although there are transdiagnostic programs available (e.g.,
Titov et al., 2011) and emerging programs to address comorbid mental
health and substance use problems (e.g., Kay-Lambkin et al., 2011,
2009), there are no integrated programs that simultaneously target
depression, anxiety disorders, substance use and suicidal ideation.
Suicidality has been shown to be resistant to depression interventions
(Christensen et al., 2013) although interventions focused on suicidal
ideation have been shown to be eﬀective (van Spijker et al., 2014a).
The development of integrated, tailored interventions that better ad-
dress comorbidity is an important next step.
Online programs are not typically targeted to individual char-
acteristics, needs and preferences. Tailored interventions may be a way
to address comorbidity. There is preliminary evidence that tailoring is
an eﬀective way to facilitate behaviour change (Lustria et al., 2013),
that tailoring to individual symptom proﬁles by clinicians can more
eﬀectively treat depression or anxiety (Carlbring et al., 2011; Johansson
et al., 2012) and that programs that account for individual preferences
tend to be more acceptable (Andersson et al., 2011; Batterham and
Calear, 2017). However, there is a pressing need to develop greater
understanding of the factors that lead to positive outcomes in internet
therapy across a range of mental health problems, to enable the de-
velopment of empirical guidelines for tailoring (Lustria et al., 2013).
Furthermore, there has been little exploration of automated tailoring in
the context of self-help online programs. Automated tailoring may use
data provided by the participant on their symptom patterns to identify
speciﬁc targeted therapeutic strategies that may be most relevant to
their symptoms, based on theory, research ﬁndings or clinical judge-
ment. No existing study has developed a transdiagnostic intervention
for the treatment of depression, anxiety, substance use and suicidal
ideation. Tailoring is one approach to handling the complexity of such a
multi-faceted intervention, to ensure that intervention materials match
the needs of the user.
The current study reports on the development and randomised
controlled trial (RCT) of a low-intensity internet-based therapy pro-
gram, called FitMindKit, that uses automated tailoring to address co-
morbid depression, anxiety disorders, substance use and/or suicidal
ideation. The intervention was developed by adapting and abridging
therapeutic techniques from existing evidence-based online programs,
on the basis that brief, targeted interventions may achieve better en-
gagement (Christensen et al., 2009). Evidence suggests that the adap-
tation of the face-to-face therapeutic model (multiple 50 min con-
sultations) may not be necessary for eﬀectively reducing symptoms of
mental health problems online (Christensen et al., 2006). Rather, a new
model of intervention focused on the core components of psychosocial
therapies that encourage overlearning of key concepts (Scott, 1992)
may be suﬃcient for eﬀective outcomes and promote greater ad-
herence. Briefer intervention components also facilitate tailoring to
individual needs by decreasing the amount of content required to pre-
sent a comprehensive, multifaceted program. The intervention selected
and combined evidence-based therapeutic elements (e.g., behavioural
activation, cognitive reframing, problem solving, exposure, motiva-
tional interviewing, mindfulness, relaxation) based on individual
symptom proﬁles. The program was aimed at adolescents and young
adults, although with relevance to the broader adult population.
The three-arm randomised controlled trial reported in this paper
aimed to test: (1) whether the FitMindKit program (tailored or un-
tailored) was eﬀective in reducing overall symptom burden in an online
population-based sample with elevated symptoms of one or more
common mental disorders, relative to an attention control program, and
(2) whether tailoring of the program to individual symptom proﬁles
increased intervention eﬀectiveness, adherence or satisfaction.
2. Method
2.1. FitMindKit intervention – static and tailored
The FitMindKit intervention was developed by using a narrative
approach to introduce the core strategies of relevant behavioural
therapies. A total of 18 modules were developed: ten core transdiag-
nostic modules, along with two domain-speciﬁc modules each for
symptoms of distress/mood disorders (major depressive disorder, MDD,
and generalized anxiety disorder, GAD), fear disorders (social anxiety
disorder, SAD, and panic disorder, PD), substance disorders (substance
use disorder, SUD, and alcohol use disorder, AUD) and suicidal idea-
tion. Speciﬁcally, the ten core modules were: psychoeducation, sources
of help for mental health problems, introduction to cognitive reframing,
problem solving strategies, introduction to mindfulness, managing re-
lationships/conﬂict resolution, exercise and diet, sleep hygiene, in-
troduction to values and committed action, and the role of stigma. The
two mood/distress modules introduced behavioural activation (for
MDD) and worry time (for GAD); the two fear modules introduced
exposure (for PD) and interpreting social cues (for SAD); the two sub-
stance use modules provided a normative comparison and introduced
motivational interviewing/identifying triggers; and the two suicidal
ideation modules introduced distress tolerance/self-soothing and emo-
tion regulation strategies.
Each module was scripted as being presented by one of ﬁve char-
acters, of whom four described having personal experience of one or
more mental health problems (the ﬁfth acted as an “expert” narrator).
The approach of having material presented by individuals with personal
experience of a mental health problem was intended to make the ma-
terial more relatable and to provide examples of modeling speciﬁc
strategies or behaviours. The modules were then developed into brief
(2–6 min) videos. The videos were developed using professionally-de-
signed cartoon characters in various poses and engaging backgrounds
and animated with Microsoft PowerPoint. Appropriate graphics illu-
strated key concepts and the videos were overlaid with character voice-
overs. The video within each module was accompanied by a relevant
“homework” activity, comprising a worksheet that was designed to
facilitate practice of the strategy presented.
The RCT compared a static version of FitMindKit (comprising the ten
core modules) to a tailored version (comprising a mixture of core and
speciﬁc modules based on symptom proﬁles) and an attention control
condition. The scheme for tailoring is provided in Figs. 1 and 2. Eleven
versions of FitMindKit are deﬁned in the Fig. 1 Venn diagram, on the
basis of comorbid mental health problems, suicidal ideation and/or
substance use. The modules delivered to participants who received each
version of the intervention are shown in Fig. 2. In this RCT, all eligible
participants met criteria (detailed in the measures Section 2.5 below)
for at least one of the targeted domains. Participants meeting criteria
for a single domain received the two speciﬁc modules for that domain,
sandwiched within a selection of an additional eight non-speciﬁc
modules (Fig. 2). Participants meeting criteria for any two domains
received the four speciﬁc modules from those two domains, sandwiched
within a selection of an additional six non-speciﬁc modules (Fig. 2).
Where criteria were met for 3–4 domains, a hierarchy was used to select
the most pressing areas of need, detailed in Fig. 1. The static version of
the intervention is labelled as “version 1” in Figs. 1 and 2.
2.2. Attention control condition
Participants in the attention control condition received the online
HealthWatch program, which has no speciﬁc mental health or sleep-
related content and is not associated with therapeutic reductions in
depression (Glozier et al., 2013). Modules were fully text-based and
contained information about bone health, sun exposure, food hygiene,
use of vitamins and supplements, kidney health, microbes, household
burns, respiratory viruses, heart health, and allergens.
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2.3. Participants
Participants were recruited from the social networking site
Facebook between January and August 2016, with data collection
completed in December 2016. A Facebook page was set up to describe
the study and paid Facebook advertisements were used to invite par-
ticipation. A sample advertisement read, “Register for a mental health
study: Complete a 20-min survey and a 10-day online program”, along
with the logo for FitMindKit featuring ﬁve cartoon characters (Fig. 3).
Initially, 18–25 year-old participants in Australia were targeted, as this
was the target age range for the intervention [n= 77 of the 194 par-
ticipants were recruited in this initial phase, with the remaining 117
(including 21 18–25-year-olds) recruited in the second phase]. Due to
both challenges with recruitment and an interest in a broad age range,
recruitment was later widened to include adults of any age in Australia.
Eligibility criteria for the trial included elevated, but not clinically se-
vere, scores on the symptom scales described below at the screening
survey, with no suicide attempt reported in the past year or current self-
reported high distress.
The target sample size was 570, based on detecting a moderate ef-
fect size of Cohen's d= 0.4 at post-test with 90% power, assuming 30%
attrition from the trial. It was assumed that 40% of all respondents to
the screening survey would meet criteria for the study and 75% of these
would consent to participate in the trial based on previous studies
(Batterham, 2014; Christensen et al., 2016). In addition, based on si-
milar recruitment methodology (Christensen et al., 2016), it was
Fig. 1. Schematic of the selection of tailoring pathways
used to select modules of FitMindKit in the tailored condi-
tion.
Notes: SI: suicidal ideation; AS: alcohol/substance.
Fig. 2. Brief description of the 18 modules of FitMindKit, with 11 versions of the program used in tailoring (based on Fig. 1).
Notes: alc/sub: alcohol/substance use
Fig. 3. Logo for the FitMindKit intervention, including the ﬁve characters featured in the
videos.
P.J. Batterham et al. Internet Interventions xxx (xxxx) xxx–xxx
3
assumed that 90% of individuals who clicked the screening survey link
would not proceed to complete the screening survey. Consequently, we
anticipated that the study would require 19,000 individuals to click on
the screening survey link to reach the recruitment target. The target
sample size was not reached because the cost of advertising was higher
than in previous studies (Christensen et al., 2016; Batterham, 2014;
Thornton et al., 2016) – advertisements attracted fewer clicks, with
approximately half as many clicks achieved within the allocated
budget. In addition, there was greater non-completion of initial as-
sessments than anticipated. The study also had higher attrition than
anticipated in comparison to previous online trials (Christensen et al.,
2016).
2.4. Procedure
Participants completed a 5 min screening survey to assess eligibility,
followed by a 15 min baseline survey. They were then randomised to
receive the static intervention, tailored intervention or attention control
(described above) with approximately equal allocations across the three
conditions using simple randomisation. The randomisation protocol
was computer-based and devised by a researcher independent of the
trial, such that the trial researchers were blinded to allocations.
On each of the ﬁrst 10 days during the intervention period, parti-
cipants were sent an email containing a daily link to a new module,
along with links to modules that they had previously received to en-
courage practice of learned strategies. Participants were given a total of
14 days to complete and practice the 10 modules. On the day following
the completion of the ﬁnal module, participants were invited by email
to complete a 15 min post-test survey. They received additional re-
minders to complete the survey if they had not done so after one and
two weeks. An identical email reminder schedule was used for a 15 min
3-month follow-up survey (due 3 months after the ﬁnal module). The
post-test and 3-month follow-up surveys contained identical scales to
the baseline assessment, although several scales testing potential
moderators of eﬀectiveness (not reported in this paper) appeared in the
baseline only, while items regarding satisfaction and engagement with
the intervention appeared only in the post-test survey. The CONSORT
diagram of participant ﬂow through the study is presented in Fig. 4. The
trial is registered at the Australian New Zealand Clinical Trials Registry
(ACTRN12615001211550) and ethical approval was obtained from the
Australian National University Human Research Ethics Committee
(protocol #2015/114).
2.5. Measures
The primary eﬀectiveness outcome was a composite of multiple
symptom measures, an indicator of overall severity of mental health
symptoms. This measure was created using a standardised score
(M= 0, SD= 1) of the sum of standardised scores for each of the seven
measures of speciﬁc mental health problems, allowing trends across the
multiple domains to be examined. The secondary eﬀectiveness out-
comes were based on each of the seven individual symptom scales.
Tertiary outcomes were adherence to and satisfaction with the inter-
vention. Speciﬁc measures are described below.
MDD symptoms were assessed using the Patient Health
Questionnaire-9 (PHQ-9; Spitzer et al., 1999), with scores ranging from
0 to 27. GAD symptoms were assessed using the Generalized Anxiety
Disorder-7 (GAD-7; Spitzer et al., 2006), range 0–21. PD and SAD
symptoms were assessed using the Panic Disorder Screener (PADIS;
range 0–13) and Social Phobia Screener (SOPHS; range 0–20) respec-
tively (Batterham et al., 2015a; 2016b). Symptoms of AUD and SUD
were measured with the Alcohol Use Disorders Identiﬁcation Test
(AUDIT; range 0–40) and Drug Use Disorders Identiﬁcation Test
(DUDIT; 0–44) respectively (Babor et al., 2001; Berman et al., 2005).
Finally, the Suicidal Ideation Attributes Scale (SIDAS; range 0–50; van
Spijker et al., 2014b) was used to assess severity of suicidal thinking.
Each of these brief self-report scales has been demonstrated to have
robust psychometric properties for the construct of interest and accu-
rately reﬂects presence of the mental health problem in the general
population. The score ranges for inclusion in the trial were as follows
(with participants needing to meet lower bound criterion on one or
more scales): PHQ-9 score of 10–19; GAD-7 score of 6–15; PADIS score
of 1–6; SOPHS score of 5–12; AUDIT score of 5–15; DUDIT score of 1–6;
and/or SIDAS score of 1–20. Cut-points were chosen based on both
existing criteria for moderate symptoms, but also population data,
where available, corresponding to the 70th–90th percentile range of
symptoms in general population samples (Anstey et al., 2011;
Batterham et al., 2016a). Respondents with a score above the moderate
clinical cutoﬀ on any of these scales at screening were excluded from
the trial, as were respondents with scores below the minimum on all
seven measures. Those who were excluded due to high scores were
provided with online and telephone help-seeking resources. All mea-
sures were repeated at post-test and follow-up assessments.
Adherence to the intervention was compared on the basis of number
of modules completed (automatically collected within the research
portal). Satisfaction was assessed using a scale of seven items devised
by the authors, related to how much the participant: enjoyed the pro-
gram, found it helpful, understood the content, found it interesting,
Fig. 4. CONSORT diagram of participant ﬂow through the trial.
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would use it in the future, would recommend it to others, and learnt
new skills from the program. Each satisfaction item was rated on a 0–10
scale from 0 “completely disagree” to 10 “completely agree”. Items
were compared both separately and combined (sum score) to identify
diﬀerences between conditions.
2.6. Analysis
Sample characteristics were provided to describe the participants
and compare intervention groups. Primary (composite of symptom
scales) and secondary (individual symptom scales) outcomes were as-
sessed using mixed model repeated measures ANOVA (MMRM; Verbeke
and Molenberghs, 2000) to account for missing data and to include all
available data for participants analysed in the trial. This approach
provides an intention-to-treat analysis to compare the intervention
groups, yielding unbiased estimates of intervention eﬀects. An un-
structured variance-covariance matrix was assumed and degrees of
freedom (df) were estimated with Satterthwaite's correction. In MMRM,
the critical test of the eﬀectiveness of the intervention is the two-way
interaction between time and condition.
To test eﬃcacy of the FitMindKit intervention, analyses were re-es-
timated excluding participants who did not complete any modules of
the interventions, and among participants who completed the majority
of the intervention. In addition, to test whether the intervention was
more eﬀective in speciﬁc age or gender groups, moderation was tested
using three-way interaction eﬀects between time, condition and mod-
erator (18–24 vs. 25+; male vs female). Diﬀerences in adherence
(module completion) and satisfaction were assessed using one-way
ANOVA across the three conditions and t-tests for pairwise compar-




Table 1 displays the sample characteristics across intervention
conditions. There were no diﬀerences between conditions at baseline
except that participants in the Static group had signiﬁcantly higher
alcohol use than in the other conditions. Participants were pre-
dominantly female, and young adults dominated the sample by design.
Other demographic factors were largely reﬂective of the general po-
pulation. Participants had slightly elevated symptoms across all mental
health measures, although generally in the healthy-mild range. Based
on the identiﬁed cut-points for each scale, only 11% of the sample had
depression symptoms in the moderate range, 25% had moderate GAD
symptoms, 22% had moderate symptoms of panic, 21% had moderate
social anxiety scores, 14% had indication of harmful alcohol use, 9%
reported any drug use, while 64% reported suicidal thinking. As an-
ticipated, there was high comorbidity, with most participants (n= 152,
78%) meeting criteria in more than one domain, and 41% (n= 80)
meeting criteria for four or more domains. There were no baseline
diﬀerences between the 75 participants who completed the post-test
assessment and the 119 who did not, except that PADIS scores were
signiﬁcantly higher among non-completers (t= 2.3, df= 191,
p= 0.021).
3.2. Eﬀectiveness on the basis of the primary composite outcome
Participants in all conditions had a signiﬁcant decrease in overall
burden of mental health symptoms over time (F= 4.3, df= 2, 61.2,
p= 0.017). However, no signiﬁcant condition × time interaction was
observed (F= 0.6, df= 2, 61.2, p= 0.640), indicating that there was
no diﬀerence in symptom reduction between conditions. Fig. 5 shows
mean (SE) composite scores at each time point for each condition, es-
timated from the MMRM. Eﬀect sizes at post-test and 3-month follow-
up are displayed in Table 2 for both the primary composite outcome
and the speciﬁc symptom measures. Eﬀect sizes were mixed and in-
consistent. Participants in all groups tended to show small-moderate
improvements over time. Particular exceptions were small increases in
depression scores in the tailored condition at 3 months, small increases
in social anxiety in the tailored condition at post-test, a large increase in
drug use at 3 months for the static condition, a small increase in drug
use at post-test in the control condition, and a small increase in suicidal
thoughts at 3 months in the control condition. However, the calculation
of eﬀect sizes were based on completer data, and deteriorations were
not signiﬁcant in MMRM analyses.
3.3. Eﬀectiveness on the basis of speciﬁc symptom measures
Similar to the composite measure, signiﬁcant decreases were ob-
served in some of the speciﬁc symptom measures over time, including
GAD-7 scores (F= 10.6, df= 2, 68.2, p < 0.001), SOPHS scores
(F= 4.4, df= 2, 67.1, p= 0.016) and AUDIT scores (F= 4.4, df= 2,
60.7, p= 0.017). No signiﬁcant decrease was observed in PHQ-9,
PADIS, DUDIT or SIDAS scores. Moreover, no signiﬁcant condition ×
time interactions were observed.
3.4. Intervention adherence
Adherence to the intervention was low, with 43 (22%) participants
not completing any modules of the intervention (16/24% in the tailored
condition; 10/16% in the static condition; 17/26% in the control con-
dition) and only 66 (34%) completing the majority of modules (≥5
modules: 33%, 31% and 38% respectively in the three conditions).
Overall, participants completed a mean of 3.9 (SD= 3.8) of the ten
modules. Among participants who began the intervention (n= 151),
on average 5.0 (SD= 3.6) modules were completed. Although module
completion was higher in the tailored condition (M= 4.0, SD= 3.7)
than the static condition (M= 3.6, SD= 3.4), this diﬀerence was not
signiﬁcant (t= 0.713, df= 126, p= 0.48; Cohen's d= 0.12).
Due to low adherence, we also wanted to test whether the inter-
vention showed a signiﬁcant eﬀect among individuals who had com-
pleted any modules, and among individuals who had completed the
majority of the intervention. As with the primary analyses, there were
no signiﬁcant condition × time eﬀects observed for the composite
outcome, nor for the speciﬁc symptom outcomes.
3.5. Testing moderation by age or gender
No signiﬁcant moderation eﬀects were found by age group or
gender, indicating that no diﬀerential eﬀects existed within age or
gender groups.
3.6. Comparison of satisfaction
Satisfaction with the intervention is shown in Fig. 6. Overall sa-
tisfaction ratings (sum score) at post-test were highest in the tailored
condition (M= 7.0, SD= 1.9), followed by the static condition
(M= 6.4, SD= 1.9) and the control condition (M= 5.7, SD= 2.2).
Although the diﬀerence between all conditions was not signiﬁcant
(F= 2.7, df= 1, 50, p= 0.07), a priori analyses of group diﬀerences
found a signiﬁcant diﬀerence between the tailored and control groups
(t= 2.3, df= 50, p= 0.029) in overall satisfaction. There were also
signiﬁcant eﬀects on speciﬁc forms of satisfaction as shown in Fig. 6:
tailored/static participants found the intervention more helpful
(F= 3.7, df= 1, 50, p= 0.030), were more likely to recommend it to
others (F= 6.9, df= 1, 50, p= 0.002), and reported that it taught
them more skills (F= 6.3, df= 1, 50, p= 0.003) compared to control
participants.
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4. Discussion
The current trial found no evidence for the eﬀectiveness of the
FitMindKit program in reducing overall symptoms of mental health and
substance use problems, nor evidence for reductions in speciﬁc
symptom domains. There were only small and inconsistent improve-
ments in most mental health symptom domains over time in all three
conditions. Further exploration of interventions that address comorbid
conditions may be worthwhile, particularly given the high rates of
comorbid mental health problems seen in the present sample and in
national population surveys (Kessler et al., 2005; Slade et al., 2009).
This lack of between-group eﬀects may reﬂect the control condition
being an active comparator, volatility in the estimates due to small
sample sizes, insuﬃcient engagement with the intervention or in-
suﬃcient intensity of the intervention. The sample also had limited
Table 1








n % n % n %
Gender 3.4 0.49
Male 7 (11%) 10 (16%) 7 (11%)
Female 58 (88%) 50 (81%) 59 (89%)
Other 1 (2%) 2 (3%) 0 (0%)
Age group 8.1 0.23
18–25 36 (55%) 29 (47%) 33 (50%)
26–45 12 (18%) 11 (18%) 9 (14%)
46–65 10 (15%) 20 (32%) 18 (27%)
> 65 8 (12%) 2 (3%) 6 (9%)
Education 4.1 0.67
High school or less 26 (39%) 20 (32%) 24 (36%)
Certiﬁcate/diploma 13 (20%) 10 (16%) 11 (17%)
Bachelor's degree 19 (29%) 16 (26%) 17 (26%)
Postgraduate degree 8 (12%) 16 (26%) 13 (20%)
Employment 2.3 0.89
Full-time 11 (17%) 16 (26%) 16 (24%)
Part-time 28 (42%) 25 (40%) 26 (39%)
Unemployed 9 (14%) 6 (10%) 6 (9%)
Not in the work force 18 (27%) 15 (24%) 17 (26%)
Location 1.6 0.82
Metropolitan 33 (50%) 32 (52%) 35 (53%)
Regional 25 (38%) 26 (42%) 25 (38%)
Rural 8 (12%) 4 (6%) 5 (8%)
Language spoken at home 1.0 0.61
English 60 (91%) 59 (95%) 62 (94%)
Other 6 (9%) 3 (5%) 3 (5%)
Symptom measures M (SD) M (SD) M (SD) F p
Depression (PHQ-9) 8.33 (4.16) 7.89 (4.75) 9.13 (4.51) 1.2 0.29
Generalized anxiety (GAD-7) 6.38 (4.23) 6.16 (3.98) 7.22 (3.84) 1.2 0.29
Panic (PADIS) 1.59 (2.14) 1.45 (2.01) 1.72 (1.88) 0.3 0.75
Social anxiety (SOPHS) 4.24 (3.20) 4.71 (3.83) 4.34 (3.66) 0.3 0.74
Alcohol use (AUDIT) 3.02 (3.48) 5.31 (3.85) 3.18 (3.03) 8.6 < 0.001
Drug use (DUDIT) 0.29 (0.87) 0.42 (1.18) 0.17 (0.82) 1.1 0.35
Suicidal ideation (SIDAS) 4.03 (4.91) 4.27 (4.66) 3.89 (4.86) 0.1 0.90
Note: bold values indicate p < 0.05
Fig. 5. Estimated marginal means (SE) from mixed model repeated measures ANOVA for
composite mental health/substance/suicidal ideation scores over time in the three con-
ditions.
Table 2
Raw within-group eﬀect sizes at post-test and 3 months.
Tailored Static Control
Post-test 3 month Post-test 3 month Post-test 3 month
Composite 0.18 −0.02 0.56 0.16 0.24 0.47
Depression
(PHQ-9)




0.47 0.23 0.48 0.67 0.35 0.51
Panic (PADIS) 0.14 0.07 0.42 0.35 0.33 0.38
Social anxiety
(SOPHS)
−0.15 −0.07 0.36 0.45 0.21 0.24
Alcohol use
(AUDIT)
0.09 0.03 0.20 0.13 0.04 0.33
Drug use
(DUDIT)
−0.05 −0.22 0.19 −1.39 −0.17 −0.02
Suicidal ideation
(SIDAS)
0.24 0.04 0.18 0.14 −0.08 −0.27
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scope for improvement in many of the symptom domains – for example,
only 11% of the sample had moderate depression symptoms, 14% had
indication of harmful alcohol use, and 9% reported any drug use,
leading to potential ﬂoor eﬀects. Consequently, subsidiary outcomes
such as increased coping and self-eﬃcacy may be useful to measure in
future trials with relatively healthy samples. Possible explanations for
the ﬁndings are discussed further below.
Adherence to the intervention appeared to slightly favour the tai-
lored intervention condition, although diﬀerences were not signiﬁcant.
More importantly, participants in the tailored condition had sig-
niﬁcantly greater overall satisfaction with their program than control
participants. Participants in the active intervention (tailored/static)
also reported their program was signiﬁcantly more helpful, were sig-
niﬁcantly more likely to recommend it, and reported learning sig-
niﬁcantly more skills than participants in the control condition.
Participants in all conditions found the content easy to understand. As
positive diﬀerences in satisfaction between intervention and active
control conditions are not always observed (Kaltenthaler et al., 2008;
Griﬃths et al., 2017), it appears likely that participants found the
format and content of the intervention to be engaging. The present
study found clear evidence that participants had greater satisfaction
with the FitMindKit program than an attention-control program. Find-
ings also suggest that with a larger sample, there remains the possibility
that beneﬁts may be found in terms of symptom reductions and ad-
herence related to the tailored program.
There were two major challenges of trialling the FitMindKit program
in a fully-automated online setting. Firstly, when participants are not
personally engaged with a project and have no interaction with a re-
searcher, it is diﬃcult to recruit and maintain engagement (Todkill and
Powell, 2013; Christensen et al., 2016), even in brief trials such as this
one. While we had hoped for greater engagement based on previous
trials with online recruitment (Christensen et al., 2016), the absence of
personal interaction may have been a barrier to ongoing engagement
for many participants. There is a need for further research on how best
to engage with participants in research that is conducted in an entirely
online setting without personal contact. The trial did not have a suﬃ-
cient sample to adequately test the eﬀectiveness of the program. Sec-
ondly, the FitMindKit program addresses a broad range of mental health
problems. As a result, it is challenging to recruit a suﬃciently large
sample of individuals who have elevated symptoms across a range of
mental health conditions (seven domains in the current study). There-
fore, it is diﬃcult to capture change across all of the mental health
domains targeted by the intervention. A less ambitious transdiagnostic
intervention approach, potentially focusing only on internalising
symptoms (e.g., 3–4 domains), might be warranted. This challenge was
further compounded by the low adherence to the intervention and high
attrition from assessments, considerably reducing the study's power to
ﬁnd eﬀects. Acceptance facilitation (Ebert et al., 2015) and similar
approaches could be further explored for increasing adherence in un-
guided interventions.
Furthermore, the intervention was designed to be low-intensity to
enable targeting of multiple comorbid mental health and substance use
problems. It is possible that the brevity of the intervention reduced its
eﬀectiveness. In addition, the rapid pace of module presentation (daily
delivery) may have become a barrier to completing the intervention for
some participants. Although our previous research has supported
community preferences for rapid delivery of brief modules (Batterham
and Calear, 2017), it may be the case that more time is needed for
participants to fully engage with material, to consolidate their under-
standing of therapeutic concepts and to not become overwhelmed if
they fall behind schedule. Full completion of the program as intended
would require at least 2–3 h, including watching ten videos (~1 h) and
completing activities (> 1 h). Such a “dosage” of internet therapy has
previously been shown to have an eﬀect on depression symptoms
(Christensen et al., 2006). Although the videos appeared to be engaging
and participants were largely satisﬁed with the content and delivery,
greater interactivity may be needed to encourage users to engage with
the therapeutic strategies presented. The activities presented in con-
junction with the videos were static (text and images); greater inter-
activity and ability for participants to monitor their progress might be
necessary to promote suﬃcient practice of the therapeutic material,
with a greater emphasis on overlearning (Scott, 1992). Techniques to
improve interactivity may include the use of persuasive systems design
(Oinas-Kukkonen and Harjumaa, 2008) and/or gamiﬁcation (Deterding
et al., 2011) that actively emphasise, among other principles, beha-
vioural feedback.
There were a number of other limitations of the trial that should be
noted. All outcomes were based on self-reported symptoms. Some of the
scales were not normally distributed; however, the lack of signiﬁcant
eﬀects observed would be unlikely to change if non-parametric models
were used. Participants were selected on the basis of elevated symp-
toms, an indicated prevention approach. It is possible that this program
would be more appropriate in a universal prevention context, such as in
a school setting (Calear and Christensen, 2010), or in a clinical context
as an adjunct to therapy. While the present trial was underpowered to
ﬁnd diﬀerential eﬀects by age or gender, it is possible that the design of
the program (including the character artwork, character voices and
examples provided) might be more appealing to a younger audience.
The trial was opened to adults of all ages due to challenges in meeting
recruitment targets. Young people may have been less inclined to
Fig. 6. Satisfaction ratings by condition
(error bars indicate SD).
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engage with an online trial than older adults, as they may be time-poor
and unable to commit to the completion of assessments in particular.
The absence of direct human contact in the trial may have been an
additional barrier to the completion of assessments and the interven-
tion. In addition, alternative formats for delivery, such as email or an
app, may also be more appropriate for such a low-intensity program.
Further examination of the eﬀects of speciﬁc modules and their
order of presentation may also be beneﬁcial, as it remains unclear
which speciﬁc strategies are most beneﬁcial to individuals with a par-
ticular pattern of symptoms. Such research might take into account
both needs (on the basis of symptom patterns) and individual pre-
ferences for addressing the speciﬁc problems that they perceive to be
most salient. Ultimately, a dynamic tailored intervention that responds
to the changing needs and preferences of the individual may further
facilitate engagement with complex internet interventions. Assessment
of clinical states using a structured clinical interview may also better
determine whether such low-intensity interventions may have impact
in a prevention or treatment context.
5. Conclusions
The FitMindKit program was designed as a tailored internet inter-
vention targeting a broad range of comorbid mental health and sub-
stance use problems. This trial did not ﬁnd evidence that the inter-
vention was eﬀective. Participants were more satisﬁed with the
program than an active control condition, suggesting the content and
design of FitMindKit were acceptable. A more comprehensive or more
targeted version of the program with greater interactivity might have
scope for reducing comorbid mental health problems in the community.
Identifying appropriate content, duration, delivery methods and target
populations is important to progressing the development of transdiag-
nostic interventions.
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